Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

Share Price is delayed by 15 minutes
Get Live Data
127.50    5.25 (4.29%)
Bid:
128.50
Ask:
129.50
Spread: 1.00 (0.778%)
Market Cap: £203.13m
RCN Live PriceLast checked at - London Stock Exchange

Intraday Redcentric Share Chart

Director/PDMR Shareholding

23 Dec 2020 07:00

RNS Number : 6037J
Redcentric PLC
23 December 2020
 

Redcentric plc

 

Director/PDMR Shareholding, Issue of Equity and Total Voting Rights

 

Redcentric plc (AIM: RCN) ("Redcentric" or the "Company"), a leading UK IT managed services provider, announces that on 22 December 2020 it received notification of exercise from each of Peter Brotherton, Chief Executive Officer, and David Senior, Chief Financial Officer, in relation to nil-cost share options ("Options") over ordinary shares of 0.1p each in the Company ("Ordinary Shares"), pursuant to the Company's 2017 Long Term Incentive Plan (the "Exercise"), as follows:

· Peter Brotherton exercised 192,481 Options. Following the Exercise, Mr Brotherton sold 97,481 Ordinary Shares at a price of 110 pence per Ordinary Share on 22 December 2020 in order to cover the tax and national insurance liability associated with the Exercise. Following the Exercise and the sale of shares, Mr Brotherton holds 228,571 Ordinary Shares in the Company (representing approximately 0.15% of the Company's issued share capital) and 921,061 share options in the Company;

· David Senior exercised 29,100 Options. Following the Exercise, Mr Senior sold 14,550 Ordinary Shares at a price of 110 pence per Ordinary Share on 22 December 2020 in order to cover the tax and national insurance liability associated with the Exercise. Following the Exercise and the sale of shares, Mr Senior holds 43,121 Ordinary Shares in the Company (representing approximately 0.03% of the Company's issued share capital) and 249,555 shares options in the Company.

Accordingly, application has been made for 221,581 new Ordinary Shares to be issued pursuant to the option exercise to be admitted to trading on AIM ("Admission"). Admission is expected to occur at 8.00 a.m. on or around the 31 December 2020.

Following Admission, the Company's issued share capital will consist of 156,165,710 Ordinary Shares, 37,569 of which are held in Treasury. For reporting under the FCA's Disclosure Guidance and Transparency Rules, shareholders should exclude any shares held in Treasury and should use the figure of 156,128,141 Ordinary Shares (the issued voting share capital) when determining if they are required to notify their interest, or a change of their interest in the Company.

Following the Exercise there are options outstanding over 3,891,750 Ordinary Shares, representing 2.49% of the Company's issued share capital.

Enquiries:

Redcentric plc

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

 

+44 (0)800 983 2522

finnCap Ltd - Nomad and Sole Broker

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

+44 (0)20 7220 0500

The notifications below, made in accordance with the requirements of the Market Abuse Regulation, provide further detail.

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Peter Brotherton

 

2.

Reason for the Notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p

Identification code

RCN GB00B7TW1V39

b)

Nature of the transaction

- Exercise of options granted under the Redcentric plc 2017 Long Term Incentive Plan

- Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Date of transaction(s)

Nil cost

192,481 options exercised

22 December 2020

110p

97,481 ordinary shares sold

22 December 2020

 

 

d)

Aggregated information:

· Aggregated volume

· Price

See 4 (c) above

e)

Date of the transactions

See 4 (c) above

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

David Senior

 

2.

Reason for the Notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Redcentric plc

b)

LEI

213800FGYMMNE9OKFD14

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary Shares of 0.1p

Identification code

RCN GB00B7TW1V39

b)

Nature of the transaction

- Exercise of options granted under the Redcentric plc 2017 Long Term Incentive Plan

- Sale of ordinary shares

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Date of transaction(s)

Nil cost

29,100 options exercised

22 December 2020

110p

14,550 ordinary shares sold

22 December 2020

 

 

d)

Aggregated information:

· Aggregated volume

· Price

See 4 (c) above

e)

Date of the transactions

See 4 (c) above

f)

Place of the transaction

London Stock Exchange, AIM Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHTTBJTMTTTTPM
Date   Source Headline
26th Apr 20187:00 amRNSAward of public sector framework agreement
19th Apr 20187:00 amRNSTrading Statement
3rd Apr 20183:32 pmRNSHolding(s) in Company
16th Mar 201812:29 pmRNSHolding(s) in Company
16th Mar 201812:28 pmRNSHolding(s) in Company
13th Mar 201812:55 pmRNSHolding(s) in Company
13th Mar 201812:49 pmRNSHolding(s) in Company
12th Mar 20182:10 pmRNSHolding(s) in Company
2nd Mar 201811:45 amRNSHolding(s) in Company
2nd Mar 201810:01 amRNSHolding(s) in Company
28th Feb 201812:40 pmRNSHolding(s) in Company
21st Feb 20187:00 amRNSHolding(s) in Company
5th Feb 20187:00 amRNSDirectorate Change
23rd Jan 20188:16 amRNSHolding(s) in Company
23rd Jan 20187:00 amRNSExercise of Options
28th Dec 201711:09 amRNSHolding(s) in Company
4th Dec 20177:00 amRNSIssue of Options
29th Nov 20177:00 amRNSHalf Year Results
24th Nov 20179:37 amRNSHolding(s) in Company
31st Oct 20175:52 pmRNSHolding(s) in Company
31st Oct 20175:51 pmRNSHolding(s) in Company
20th Oct 20177:00 amRNSDirectorate Change
5th Oct 20177:00 amRNSAppointment of CEO and Trading Update
21st Sep 20176:06 pmRNSIssue of Options
20th Sep 20174:53 pmRNSSave As You Earn Share Option Scheme
5th Sep 20174:36 pmRNSResult of AGM
4th Sep 20178:38 amRNSAGM Statement - correction
4th Sep 20177:00 amRNSAGM Trading Statement
24th Aug 20171:52 pmRNSHolding(s) in Company
16th Aug 201712:01 pmRNSDirector Shareholding
15th Aug 20179:12 amRNSDirector Shareholding
15th Aug 20178:57 amRNSHolding(s) in Company
10th Aug 20177:00 amRNSDirectorate Change
4th Aug 20175:03 pmRNSPublication of Annual Report and Notice of AGM
27th Jul 20179:35 amRNSHolding(s) in Company
5th Jul 20177:00 amRNSDirector Shareholding
29th Jun 20177:00 amRNSPreliminary Announcement for y/e 31st March 2017
13th Jun 20173:20 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
13th Jun 20177:00 amRNSAppointment of Non-Executive Director
23rd May 20172:55 pmRNSHolding(s) in Company
23rd May 20172:55 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
5th May 20177:00 amRNSTrading Statement
22nd Mar 20175:09 pmRNSHolding(s) in Company
20th Mar 20177:00 amRNSRegulatory Update
16th Mar 20174:56 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
13th Mar 20173:05 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
9th Mar 201710:08 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
8th Mar 20175:15 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
6th Mar 20174:58 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
3rd Mar 20172:13 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.